The authors state, “Our results demonstrate that the therapeutic potential of IH is modified by sex and apolipoprotein E genotype.” They should be careful with a conclusion like this, as they don’t observe a therapeutic-type effect of IH in their mouse model. The gene discussed is APOE; the disease is isolated hemihyperplasia.